CAS: 14293-44-8; 4-Chloro-N-(2,6-Dimethylphenyl)-2-Hydroxy-5-Sulfamoylbenzamide

该化合物是一种类似硫化物的二尿素药物,主要用于治疗与心脏衰竭或肾病有关的高血压和水肿,其作用是抑制钠重新吸附在肾脏分解管内,导致尿液输出增加,血液量减少.Xipamide的特征是其化学结构,其中包括一个全氟辛烷磺酸组,造成其二尿质性能.它一般是口服的,有中度作用,作用持续数小时.该物质以水溶性相对较低而著称,可影响其生物利用率和吸收率.此外,xipamide可能与其他药物发生相互作用,并可能造成副作用,例如电解不平衡,特别是低血压.建议治疗期间监测肾功能和电解水平.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-10925977-B2
    优先权日:2006-10-05
    标 题 :Efficient synthesis of chelators for nuclear imaging and radiotherapy: compositions and applications
    发明人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S
    权利人:YANG DAVID J; YU DONGFANG; THOMPSON ANDREW S; CEIL POINT LLC; UNIV TEXAS
    摘要:Novel methods of synthesis of chelator-targeting ligand conjugates, compositions comprising such conjugates, and therapeutic and diagnostic applications of such conjugates are disclosed. The compositions include chelator-targeting ligand conjugates optionally chelated to one or more metal ions. Methods of synthesizing these compositions in high purity are also presented. Also disclosed are methods of imaging, treating and diagnosing disease in a subject using these novel compositions, such as methods of imaging a tumor within a subject and methods of diagnosing myocardial ischemia.

    专利号:US-2008287407-A1
    优先权日:2003-12-10
    标题 :Nitric Oxide Releasing Pyruvate Compounds, Compositions and Methods of Use
    发明人:GARVEY DAVID S; FANG XINQIN; KHANAPURE SUBHASH P; RANATUNGA RAMANI R; WEY SHIOW-JYI
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated and/or nitrosylated pyruvate compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated and/or nitrosylated pyruvate compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one pyruvate compound and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one pyruvate compound, that is optionally nitrosated and/or nitrosylated, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating diseases resulting from oxidative stress, diabetes, reperfusion injury following ischemia, preservation of tissues, organs, organ parts and/or limbs.

    专利号:US-11696954-B2
    优先权日:2017-04-28
    标题 :Synthesis of spherical nucleic acids using lipophilic moieties
    发明人:KANG RICHARD; NALLAGATLA SUBBARAO; ANDERSON BART; KANDIMALLA EKAMBAR
    权利人:EXICURE OPERATING COMPANY
    摘要:Spherical nucleic acids (SNA) carrying self-aggregating oligonucleotides are described herein. Compositions of the SNA include discrete nanostructures that are not aggregated. Related methods are also described.

    专利号:US-2023301584-A1
    优先权日:2022-01-26
    标 题 :Nanosensor for real-time monitoring of wound healing, manufacturing method thereof, and real-time monitoring system for wound healing using same
    发明人:JANG WOO YOUNG; HWANG JANGSUN; XU CHENJIE
    权利人:UNIV KOREA RES & BUS FOUND; UNIV CITY HONG KONG
    摘要:The present disclosure relates to a nanosensor for real-time monitoring of wound healing, a manufacturing method thereof, and a real-time monitoring system for wound healing using the same. A nanosensor according to example embodiments includes a biomarker for detecting mRNA and a reference gene on gold nanoparticles, thereby providing an objective indicator through monitoring of wound healing, enabling monitoring of wound healing through direct monitoring using real-time fluorescence by including a fluorescent marker in a nanoflare, and enabling evaluation of a whole wound healing process in normal and patient groups (diabetes) through real-time monitoring. In addition, the nanosensor according to the example embodiments has advantages of shortening synthesis time and improving efficiency by 30% through integration of a novel synthesis method (freezing method) rather than an existing synthesis method (salt aging).

    专利号:US-11458114-B2
    优先权日:2020-05-19
    标 题:Methods and compositions for enhancing synthesis secretion and transport of collagen to increase wound strength
    发明人:MARTIN ALAIN
    权利人:MARTIN ALAIN; NORTH CELL PHARMACEUTICALS INC
    摘要:A method for, and medicinal composition for, treatment of mammalian cells for enhancing synthesis, secretion and transport of collagen to increase wound strength, that includes magnesium pyruvate; calcium pyruvate; L proline; citrulline: and a liquid carrier.

    专利号:US-2008227851-A1
    优先权日:2007-03-12
    标题 :Laulimalide and laulimalide analogs
    发明人:WENDER PAUL A
    权利人:WENDER PAUL A
    摘要:Novel laulimalide analogs, methods for the treatment of proliferative disease and processes for the synthesis of laulimalide and novel laulimalide analogs are described.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Tolba MM, Belal F. Two liquid chromatographic approaches for the simultaneous determination of xipamide and its degradation product (2,6-xylidine) using time-programmed fluorescence detection. Luminescence. 2017 Jun;32(4):491-501. doi: 10.1002/bio.3203. Epub 2016 Aug 26. doi: 10.1515/acph-2016-0022. doi: 10.1007/s10895-013-1301-z. Epub 2013 Oct 4. doi: 10.1016/j.jpba.2011.11.032. Epub 2011 Dec 6. doi: 10.1002/dta.92. German. French. German. Review.

    合成参考文献


    参考文献:10.1007/bf00561678
    摘要:Fleuren HLJ, Verwey-van Wissen CPW, van Rossum JM. Pharmacokinetics of mefruside and two active metabolites in man. European Journal of Clinical Pharmacology. 1980 Jan;17(1):59–69. doi: 10.1007/bf00561678.
    参考文献:10.1007/s00508-011-1591-6
    摘要:Fruhwald FM, Ulmer H, Pacher R, Pölzl G, Dornaus C, Wieser M, Ebner C, Reiter S, Kaltenbach L, Altenberger J; Arbeitsgruppe Herzinsuffizienz der Österreichischen Kardiologischen Gesellschaft. [Heart rate and functional impairment are predictors of outcome in heart failure patients in the real world. Data from the Austrian Heart Failure registry]. Wien Klin Wochenschr. 2011 Jun;123(11-12):378–83. doi: 10.1007/s00508-011-1591-6.
    参考文献:10.1007/bf02280749
    摘要:Knauf H, Mutschler E. Constant K+/Na+ excretion ratio during peak diuresis after piretanide but insignificant K+ loss during 24 hours. European Journal of Clinical Pharmacology. 1992 Jul;43(1):23–7. doi: 10.1007/bf02280749.
    参考文献:10.2165/00003495-199447040-00001
    摘要:Johnston GD. Selecting appropriate antihypertensive drug dosages. Drugs. 1994 Apr;47(4):567–75. doi: 10.2165/00003495-199447040-00001.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知